Mengovirus replication in Novikoff rat hepatoma and mouse L cells: effects on synthesis of host-cell macromolecules and virus-specific synthesis of ribonucleic acid.
Novikoff cells (strain N1S1-67) and L-67 cells, a nutritional mutant of the common strain of mouse L cells which grows in the same medium as N1S1-67 cells, were infected with mengovirus under identical experimental conditions. The synthesis of host-cell ribonucleic acid (RNA) by either type of cell was not affected quantitatively or qualitatively until about 2 hr after infection, when viral RNA synthesis rapidly displaced the synthesis of cellular RNA. The rate of synthesis of protein by both types of cells continued at the same rate as in uninfected cells until about 3 hr after infection, and a disintegration of polyribosomes occurred only towards the end of the replicative cycle, between 5 and 6 hr. The time courses and extent of synthesis of single-stranded and double-stranded viral RNA and of the production of virus were very similar in both types of cells, in spite of the fact that the normal rate of RNA synthesis and the growth rate of uninfected N1S1-67 cells are about three times greater than those of L-67 cells. In both cells, the commencement of viral RNA synthesis coincided with the induction of viral RNA polymerase, as measured in cell-free extracts. Viral RNA polymerase activity disappeared from infected L-67 cells during the period of production of mature virus, but there was a secondary increase in activity in both types of cells coincidental with virus-induced disintegration of the host cells. Infected L-67 cells, however, disintegrated and released progeny virus much more slowly than N1S1-67 cells. The two strains of cells also differed in that replication of the same strain of mengovirus was markedly inhibited by treating N1S1-67 cells with actinomycin D prior to infection; the same treatment did not affect replication in L-67 cells.
D000818:Animals; D006528:Carcinoma, Hepatocellular / Q000378:metabolism*; D046508:Culture Techniques; D003609:Dactinomycin / Q000494:pharmacology; D004686:Encephalomyocarditis virus; D007739:L Cells; D008113:Liver Neoplasms / Q000378:metabolism; D051379:Mice; D009363:Neoplasm Proteins / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D012313:RNA / Q000096:biosynthesis*; D012316:RNA Nucleotidyltransferases / Q000096:biosynthesis; D012334:RNA, Neoplasm / Q000096:biosynthesis*; D012367:RNA, Viral / Q000096:biosynthesis*; D014777:Virus Diseases / Q000378:metabolism; D014779:Virus Replication
D009363:Neoplasm Proteins; D011506:Proteins; D012334:RNA, Neoplasm; D012367:RNA, Viral; D003609:Dactinomycin; D012313:RNA; D012316:RNA Nucleotidyltransferases